非小细胞肺癌新辅助化疗的现状分析被引量：11

Analysis of current status of neoadjuvant chemotherapy for non-small cell lung cancer

导出

摘要肺癌是目前世界上对人类健康威胁最大的恶性肿瘤。目前对于早期及局部进展期可手术切除的非小细胞肺癌患者,国内外指南均推荐采用手术、化疗、放疗多种模式综合治疗。最新研究表明,新辅助化疗可显著改善可切除非小细胞肺癌患者的预后,且有更好的治疗依从性及耐受性。 Lung cancer has been the most dangerous malignant tumor in the worldwide.Nowadays,for patients with resectable early or local advanced non-small cell lung cancer (NSCLC),both domestic and foreign guidelines recommended multidisciplinary treatments like surgery,chemotherapy and radiotherapy.Recent studies have shown that neoadjuvant chemotherapy can significantly improve the prognosis of patients with resectable NSCLC and has better treatment compliance and tolerance.

作者李琴付振明 Li Qin;Fu Zhenming(Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China)

机构地区武汉大学人民医院肿瘤科

出处《国际肿瘤学杂志》 CAS 2019年第2期109-112,共4页 Journal of International Oncology

基金国家自然科学基金(81472971、81773555).

关键词癌非小细胞肺化学疗法辅助 Carcinoma, non-small-cell lung Chemotherapy, adjuvant

分类号 R734.2 [医药卫生—肿瘤]

引文网络
相关文献

参考文献1

1蒋晓君.Ⅲ期非小细胞肺癌序贯疗法与同步疗法研究进展[J].国际肿瘤学杂志,2014,41(6):432-435. 被引量：1

二级参考文献21

1Simard EP, Ward EM, Siegel R, et al. Cancers with increasing inci- dence trends in the United States: 1999 through 2008.
2CA Cancer J Clin[J], Epub ahead of print. Socinski MA, Rosenman JG. Chemotherapeutic issues in the manage- ment of unresectable stage ill non-small cell lung cancer[ J]. Semin Oncol, 2005, 32(2 Suppl 3) : S18-24.
3Anderson BL, Yang HC, Farrar WB, et al. Pyschologic intervention improves survival for breast cancer patients: a randomised clinical trial [J]. Cancer, 2008, 113(12) :3450-3458.
4Yoo J, Jung JH, Lee MA, et al. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis[J]. J Korean Med Sci, 2007, 22(2) : 318-325.
5Frick E, Tyroller M, Panzer M. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy : a cross-sectional study in a community hospital outpatient centre [ J ]. Eur J Cancer Care (Engl), 2007, 16(2):130-136.
6El-Sharouni SY, Kal liB, Battermann JJ, et al. Sequential versus concurrent chemo-radiotherapy in inoperable stage Ⅲ non-small cell lung cancer [ J ]. Anticancer Res, 2006, 26 ( 1 B) : 495-505.
7Senan S, Cardenal F, Vansteenkiste J, et al. A randomized phase Ⅱ study comparing induction or consolidation chemotherapy with cis- platin-docetaxel, plus radical concurrent chemoradiotherapy with cis- platin-docetaxel, in patients with unresectable locally advanced non-r rl / small-cell lung cancer [ J ]. Ann Oncol, 2011, 22 ( 3 ) : 553-558.
8Zafloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study [ J ]. Lung Cancer, 2004, 46( 1 ) :87-98.
9Lee DS, Kim YS, Kang JH, et al. Clinical responses and prognostic indicators of concurrent chemoradiation for non-small cell lung canc- er. Cancer Res Treat, 2011,43(1) :32-41.
10Wemer-Wasik M, Swann RS, Bradley J, et al. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase Ⅰ-Ⅱf radiation dose-escalation study in patients with inopera- ble non-small-cell lung cancer [ J ]. Int J Radiat Oncol Biol Phys, 2008, 70(2) :385-390.